Warning letter
Akers Biosciences, Inc. [ARCHIVED]: warning letter of Oct 4, 2011
FDA warning letter 196333 · New Jersey District Office
Key facts
| Reference number | 196333 |
|---|---|
| Company | Akers Biosciences, Inc. [ARCHIVED] |
| Subject | Premarket Approval/Adulterated |
| Issue date | Oct 4, 2011 |
| Posted date | Oct 4, 2011 |
| Issuing office | New Jersey District Office |
| Product type | Biologics |
| Inspection city | Thorofare |
| Inspection ZIP | 08086 |
| Inspection start date | Apr 26, 2011 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: